Abliva’s Chief Medical Officer, Magnus Hansson, speaks about drug development in the primary mitochondrial disease space, and Abliva’s lead candidate KL1333.
source
Mitochondria News for Athletes
Abliva’s Chief Medical Officer, Magnus Hansson, speaks about drug development in the primary mitochondrial disease space, and Abliva’s lead candidate KL1333.
source